We are live on
!
Find out more
WCM
Washington Capital Management Portfolio holdings
AUM
$152M
1-Year Est. Return
30.99%
This Fund
S&P 500
This Quarter
Est. Return
+3.8%
1 Year Est. Return
+30.99%
3 Year Est. Return
+76.9%
5 Year Est. Return
+81.36%
10 Year Est. Return
+354.14%
AUM
$88M
AUM Growth
-$326K
(-0.37%)
Cap. Flow
-$2.82M
Cap. Flow
% of AUM
-3.21%
Top 10 Holdings %
Top 10 Hldgs %
34.04%
Holding
108
New
11
Increased
23
Reduced
14
Closed
15
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$2.7M |
| 2 |
Newmont
NEM
|
+$1.86M |
| 3 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$1.68M |
| 4 |
UnitedHealth
UNH
|
+$635K |
| 5 |
Unifirst Corp
UNF
|
+$453K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Biotechnology ETF
IBB
|
+$2.33M |
| 2 |
Viatris
VTRS
|
+$2.02M |
| 3 |
GG
Goldcorp Inc
GG
|
+$1.45M |
| 4 |
SLB Ltd
SLB
|
+$1.28M |
| 5 |
Oracle
ORCL
|
+$1.18M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13% |
| 2 | Financials | 12.45% |
| 3 | Industrials | 11.92% |
| 4 | Communication Services | 9.61% |
| 5 | Technology | 8.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Box
BOX
$4.37B
| $493K | 0.56% |
28,000
| – | – |
|
52
Steris
STE
$22.3B
| $491K | 0.56% |
3,300
-1,000
| -23% | -$134K |
|
53
C.H. Robinson
CHRW
$17.4B
| $489K | 0.56% |
5,800
| – | – |
|
54
ResMed
RMD
$30.6B
| $488K | 0.55% |
4,000
| – | – |
|
55
Wells Fargo
WFC
$261B
| $487K | 0.55% |
10,300
+300
| +3% | +$14K |
|
56
Encompass Health
EHC
$11B
| $475K | 0.54% |
9,428
| – | – |
|
57
Cooper Companies
COO
$14.1B
| $472K | 0.54% |
5,600
| – | – |
|
58
Palo Alto Networks
PANW
$270B
| $458K | 0.52% |
13,500
| – | – |
|
59
ScottsMiracle-Gro
SMG
$3.82B
| $458K | 0.52% |
4,650
| – | – |
|
|
WCG
60
DELISTED
Wellcare Health Plans, Inc.
WCG
| $456K | 0.52% |
1,600
| – | – |
|
61
Regions Financial
RF
$26.4B
| $448K | 0.51% |
30,000
| – | – |
|
62
NXP Semiconductors
NXPI
$57.8B
| $439K | 0.5% |
4,500
+2,000
| +80% | +$194K |
|
63
Arthur J. Gallagher & Co
AJG
$64.1B
| $438K | 0.5% |
5,000
| – | – |
|
64
F5
FFIV
$22.9B
| $437K | 0.5% |
3,000
+750
| +33% | +$112K |
|
65
Take-Two Interactive
TTWO
$45.4B
| $420K | 0.48% |
+3,700
| New | +$381K |
|
66
Zurn Elkay Water Solutions
ZWS
$8.38B
| $393K | 0.45% |
+26,988
| New | +$363K |
|
|
ABMD
67
DELISTED
Abiomed Inc
ABMD
| $391K | 0.44% |
1,500
+450
| +43% | +$119K |
|
|
SKX
68
DELISTED
Skechers
SKX
| $387K | 0.44% |
12,300
+2,000
| +19% | +$61.7K |
|
69
Synopsys
SNPS
$74.4B
| $386K | 0.44% |
3,000
-2,000
| -40% | -$241K |
|
70
Amphenol
APH
$198B
| $384K | 0.44% |
16,000
-8,000
| -33% | -$193K |
|
|
JWN
71
DELISTED
Nordstrom
JWN
| $382K | 0.43% |
+12,000
| New | +$452K |
|
|
VAR
72
DELISTED
Varian Medical Systems, Inc.
VAR
| $381K | 0.43% |
2,800
-1,000
| -26% | -$134K |
|
|
P
73
Everpure Inc
P
$25.7B
| $374K | 0.43% |
24,500
+2,300
| +10% | +$44.9K |
|
74
Sprouts Farmers Market
SFM
$8.13B
| $374K | 0.43% |
19,800
| – | – |
|
75
Ciena
CIEN
$53.4B
| $354K | 0.4% |
+8,600
| New | +$331K |
|
Similar funds
MCCM
FA
PNC
BA
II
DIG
HEC
SHF
Washington Capital Management's Q2 2019 Portfolio in Review
As of Q2 2019, Washington Capital Management held 108 positions worth $88M, down 0.37% from $88.3M the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Washington Capital Management withdrew a net $2.82M in Q2 2019, closing 15 positions and reducing 14 holdings. Its most notable exit was iShares Biotechnology ETF, an estimated $2.33M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, down from 14% a quarter earlier, followed by Financials and Industrials.
Against the trend, Washington Capital Management opened a new position in Newmont worth $2.12M.
- Washington Capital Management's largest Q2 2019 buy was Newmont: 55,024 shares worth $2.12M.
- Washington Capital Management added most to Vanguard Morningstar Total Stock Market ETF in Q2 2019, an estimated $2.7M increase.
- Washington Capital Management's biggest Q2 2019 reduction was Synopsys, cutting an estimated $241K.
- Washington Capital Management fully exited iShares Biotechnology ETF in Q2 2019, selling an estimated $2.33M.
- Washington Capital Management's ten largest holdings make up 34% of its $88M portfolio in Q2 2019.
- Washington Capital Management opened 11 new positions and closed 15 in Q2 2019.
- Washington Capital Management's portfolio value fell 0.37% quarter-over-quarter to $88M.
Based on Washington Capital Management's 13F filing for Q2 2019, filed 7 Aug 2019.